CBD has been used in recent years to treat a variety of health conditions and ailments. From insomnia to anxiety and through to chronic pain, CBD offers natural relief to many people.
CBD is also an antiseptic, it contains anti-bacterial properties and is believed to be useful in the treatment of gum disease. Impression Healthcare, an Australian-based medical cannabis company, has just been approved for a Phase 2a Clinical Trial looking at how CBD mouthwashes and toothpaste could potentially be used to fight gum disease.
The trial intends to look at how CBD could fight conditions such as Gingivitis and Periodontitis. The study taking place in Australia is a collaboration between Impression and AXIM Biotechnologies Inc. AXIM is a pharmaceutical-grade medical cannabis producer in the US who are supplying the various CBD toothpaste and mouthwashes for the trial.